Advances in technology are stretching the definition and utility of medical devices to ever new lengths – and the regulations are following suit. Since May 2021, organisations working in the space have been expected to comply with the new …
Breaking news as it happens at PHARMASEAL
PHARMASEAL Announces Partnership with Medrio
PHARMASEAL International Ltd, a technology provider of clinical trial management and governance solutions for biopharmaceutical, CROs and medical device organizations has today announced that it has entered into a partnership agreement with …
PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company
PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning US-based company providing ultrasound technology.
The Engility® Trial …
PHARMASEAL’s £1million crowdfunding campaign aimed at increasing clinical trial turnaround times gains momentum
A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone.
Launched by the new provider of clinical trial management and governance …
An Opportunity to Shape the Future of Clinical Trials: PHARMASEAL Launches £1 million Crowdfunding Campaign
PHARMASEAL, a new provider of clinical trial management and governance solutions, today announces the launch of a £1 million crowdfunding round with Seedrs.
The capital raised will enable the company to continue commercialisation and …
Engility®CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes
PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today that a leading US health outcomes and technology company has selected Engility® Clinical Trial Management system for the management and …